AllinkBio Closes Nearly $50 Million Series A Extension, BlueRun Ventures Continues to Double Down | BlueRun Family
Accelerating Clinical Development at Full Speed
蓝驰创投
@lanchi
不被定义
358 articles
Articles
BlueRun Ventures Continues to Double Down, Zongwei Technology Closes Hundreds of Millions of RMB in Pre-C+ Round | BlueRun Portfolio
Building the "Physical Interface" for AI Implementation
In the AI Era, There Are Only Builders — No Seats on the Sidelines | Quarterly
Let's go.
Kill the Candlestick? This Startup Wants to Make the Stock Market "Speak Human" | BlueRun Ventures Family Headlines
Building an AI-Native All-in-One Trading Platform
A Group of Young People Built a "Senior Version" of Xiaohongshu to Help Retirees Live Their Best Life | BlueRun Ventures Family Headlines
A sense of purpose is essential to retirement; social connection is the antidote to loneliness.
BlueRun Ventures in Conversation with QUA Biotech, AllinkBio, and Zenitar: Breaking Out of the Red Sea — The "Value" Evolution of China's Innovative Drugs
The Leap from "Imitation and Followership" to "Original Innovation"
Winning the World's Admiration Bare-Handed in the AI Era | Buming Startup Camp Now Recruiting
Let's Get Ready to Rumble.
Genspark Closes $275M Series B, Unveils AI Workspace to Drive a New Paradigm in Work | BlueRun Family
Activating "Autopilot" for Knowledge Work
BlueRun Ventures Continues to Back RockFlow in New Tens-of-Millions USD Funding Round | BlueRun Family
Make investing accessible to everyone.
Kun Jing, Genspark: Dancing with Microsoft Agent 365, Making AI Agents Everyone's Work Partner
Stop talking, start doing.